Hep C Virus - Koronis Pharmaceuticals to Participate in Panel 'Infectious ...

Koronis Pharmaceuticals to Participate in Panel 'Infectious ...
PR Newswire (press release), NY - Feb 9, 2006... to the Company's lead product candidate, KP-1461 for AIDS/HIV, the Company has product candidates in development for the treatment of hepatitis C infection. ...

Hepatitis C Could Infect 800,000 Australians By 2020
MedIndia, India - Feb 22, 2006... be initiated. A 45 to 90% of patients can have their hepatitis C infection eradicated if interferon therapy is instituted. Liver ...

Coley Pharmaceutical Group Reports Fourth Quarter and Full Year ...
MSN Money - Feb 23, 2006... being evaluated alone and in combinations with drugs which comprise the current standard of care for the treatment of chronic Hepatitis C infection in subjects ...

ZymoGenetics Reports Fourth Quarter and Year End 2005 Financial ...
International News Service, Australia - Feb 9, 2006... Other -- The company decided to advance Interleukin-29 (IL-29) into clinical development as a potential treatment for Hepatitis C infection. ...

Coley Pharmaceutical Group Initiates Phase II Clinical Study of ...
PR Newswire (press release), NY - Feb 23, 2006... announced the initiation of a randomized Phase II clinical study of Actilon(TM) (CPG 10101) for the treatment of patients with chronic Hepatitis C infection. ...